文献速递慢阻肺呼吸道感染

COPD嗜酸性炎症的影响与关联:AERIS队列分析

Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort.
PubMed 文献 · Eur Respir J · 2017-10-12

研究前瞻性随访127例40-85岁中重度COPD患者,重复采集稳定期和急性加重72小时内血与痰标本。基线血嗜酸性粒细胞≥2%可预测全年稳定期嗜酸性粒细胞升高及加重期嗜酸性炎症风险增加,且与加重期细菌检出风险降低相关。嗜酸性炎症是常见且稳定的表型。

要点

  • 基线血嗜酸性粒细胞≥2%可预测稳定期及加重期嗜酸性炎症。
  • 嗜酸性炎症表型与加重期细菌感染风险降低相关。
  • 嗜酸性为主患者加重期细菌感染呈季节性,冬季风险高于夏季。

核心结论

  • 嗜酸性炎症是COPD常见且稳定的表型。
  • 稳定期血嗜酸性粒细胞计数可预测未来加重期炎症性质。

研究设计与样本

  • 前瞻性队列研究,纳入127例40-85岁中重度至极重度COPD患者。
  • 重复采集稳定期及加重72小时内血和痰标本,随访1年。

主要发现

  • 基线血嗜酸性粒细胞≥2%预测全年稳定期嗜酸性粒细胞升高,AUC 0.841(95%CI 0.755-0.928)。
  • 基线血嗜酸性粒细胞≥2%预测加重期嗜酸性炎症风险增加,OR 9.16(p<0.001)。
  • 加重期嗜酸性粒细胞≥2%与细菌检出风险降低相关,OR 0.49(p=0.049)。
  • 稳定期嗜酸性粒细胞为主与加重期细菌检出风险降低相关,OR 0.25(p=0.065)。
  • 嗜酸性为主患者加重期细菌感染具季节性,冬季 vs 夏季 OR 4.74(p=0.011)。

临床怎么用

  • 稳定期血嗜酸性粒细胞计数可用于预判未来加重期炎症类型。
  • 结合季节变化理解嗜酸性表型患者的细菌感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Eosinophilic inflammation in chronic obstructive pulmonary disease (COPD) predicts response to treatment, especially corticosteroids. We studied the nature of eosinophilic inflammation in COPD prospectively to examine the stability of this phenotype and its dynamics across exacerbations, and its associations with clinical phenotype, exacerbations and infection.127 patients aged 40-85 years with moderate to very severe COPD underwent repeated blood and sputum sampling at stable visits and within 72 h of exacerbation for 1 year.Blood eosinophils ≥2% was prevalent at baseline, and predicted both predominantly raised stable-state eosinophils across the year (area under the curve 0.841, 95% CI 0.755-0.928) and increased risk of eosinophilic inflammation at exacerbation (OR 9.16; p<0.001). Eosinophils ≥2% at exacerbation and eosinophil predominance at stable visits were associated with a lower risk of bacterial presence at exacerbation (OR 0.49; p=0.049 and OR 0.25; p=0.065, respectively). Bacterial infection at exacerbation was highly seasonal (winter versus summer OR 4.74; p=0.011) in predominantly eosinophilic patients.Eosinophilic inflammation is a common and stable phenotype in COPD. Blood eosinophil counts in the stable state can predict the nature of inflammation at future exacerbations, which when combined with an understanding of seasonal variation provides the basis for the development of new treatment paradigms for this important condition.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Kim VL, Coombs NA, Staples KJ, et al. Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort. Eur Respir J. 2017. PMID: 29025891. doi:10.1183/13993003.00853-2017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。